Selective cyclooxygenase-2 inhibition reverses microcirculatory and inflammatory sequelae of closed soft-tissue trauma in an animal model

Journal of Bone and Joint Surgery

Volumn 87, Issue 1, 2005, Pages 153-160

  Gierer, Philip ^a   Mittlmeier, Thomas ^a   Bordel, Reingart ^a   Schaser, Klaus Dieter ^a,b   Gradl, Georg ^a   Vollmar, Brigitte ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PARECOXIB; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFICACY; HEMODYNAMICS; HINDLIMB; HYPOXEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; MALE; MICROCIRCULATION; MUSCLE ISCHEMIA; MUSCLE LEVEL; MUSCLE PERFUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SOFT TISSUE INJURY; THROMBOCYTE; UPREGULATION; WESTERN BLOTTING;

EID: 11844265847     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.C.01510     Document Type: Article

References (46)

1. Buckwalter JA. Pharmacological treatment of soft-tissue injuries. J Bone Joint Surg Am. 1995;77:1902-14.
2. Laing DR, Dalley DR, Kirk JA. Ice therapy in soft tissue injuries. NZ Med J. 1973;78:155-8.
3. Cohn BT, Draeger RI, Jackson DW. The effects of cold therapy in the postoperative management of pain in patients undergoing anterior cruciate ligament reconstruction. Am J Sports Med. 1989;17:344-9.
4. Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs - differences and similarities. N Engl J Med. 1991;324:1716-25. Erratum in: N Engl J Med. 1991;325:747.
5. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97-120.
6. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. Cyclooxygenase in biology and disease. FASEB J. 1998;12:1063-73.
7. Andrews JR. Current concepts in sports medicine: the use of COX-2 specific inhibitors and the emerging trends in arthroscopic surgery. Orthopedics. 2000;23(7 Suppl):S769-72.
8. Berger RG. Intelligent use of NSAIDs - where do we stand? Expert Opin Pharmacother. 2001;2:19-30.
9. Elder CL, Dahners LE, Weinhold PS. A cyclooxygenase-2 inhibitor impairs ligament healing in the rat. Am J Sports Med. 2001;29:801-5.
10. Endo K, Sairyo K, Komatsubara S, Sasa T, Egawa H, Yonekura D, Adachi K, Ogawa T, Murakami R, Yasui N. Cyclooxygenase-2 inhibitor inhibits the fracture healing. J Physiol Anthropol Appl Human Sci. 2002;21:235-8.
11. Stichtenoth DO, Frolich JC. The second generation of COX-2 inhibitors: what advantages do the newest offer? Drugs. 2003;63:33-45.
12. Sokal RR, Rohlf FJ. Biometry: the principles and practice of statistics in biological research. 2nd ed. San Francisco: Freeman; 1981.
13. Schaser KD, Vollmar B, Menger MD, Schewior L, Kroppenstedt SN, Raschke M, Lubbe AS, Haas NP, Mittlmeier T. In vivo analysis of microcirculation following closed soft-tissue injury. J Orthop Res. 1999;17:678-85.
14. Dixon CE, Clifton GL, Lighthall JW, Yaghmai AA, Hayes RL. A controlled cortical impact model of traumatic brain injury in the rat. J Neurosci Methods. 1991;39:253-62.
15. Lighthall JW, Dixon CE, Anderson TE. Experimental models of brain injury. J Neurotrauma. 1989;6:83-97.
16. Tyml K, Budreau CH. A new preparation of rat extensor digitorum longus muscle for intravital investigation of the microcirculation. Int J Microcirc Clin Exp. 1991;10:335-43.
17. Vollmar B, Slotta JE, Nickels RM, Wenzel E, Menger MD. Comparative analysis of platelet isolation techniques for the in vivo study of the microcirculation. Microcirculation. 2003;10:143-52.
18. Seifert J, Messmer K. Validity of blood volume determinations in hemorrhagic shock in rats. Eur Surg Res. 1971;3:306-16.
19. Mittlmeier T, Vollmar B, Menger MD, Schewior L, Raschke M, Schaser KD. Small volume hypertonic hydroxyethyl starch reduces acute microvascular dysfunction after closed soft-tissue trauma. J Bone Joint Surg Br. 2003;85:126-32.
20. Gierer P, Vollmar B, Schaser KD, Andreas C, Gradl G, Mittlmeier T. Efficiency of small-volume resuscitation in restoration of disturbed skeletal muscle microcirculation after soft-tissue trauma and haemorrhagic shock. Langenbecks Arch Surg. 2004;389:40-5.
21. Vollmar B, Burkhardt M, Minor T, Klauke H, Menger MD. High-resolution microscopic determination of hepatic NADH fluorescence for in vivo monitoring of tissue oxygenation during hemorrhagic shock and resuscitation. Microvasc Res. 1997;54:164-73.
22. Ince C, Coremans JM, Bruining HA. In vivo NADH fluorescence. Adv Exp Med Biol. 1992;317:277-96.
23. Chance B, Cohen P, Jobsis F, Schoener B. Intracellular oxidation-reduction states in vivo. Science. 1962;137:499-508.
24. Glanemann M, Vollmar B, Nussler AK, Schaefer T, Neuhaus P, Menger MD. Ischemic preconditioning protects from hepatic ischemia/reperfusion-injury by preservation of microcirculation and mitochondrial redox-state. J Hepatol. 2003;38:59-66.
25. Menger MD, Rucker M, Vollmar B. Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of capillary "no-reflow." Shock. 1997;8:2-7.
26. Menger MD, Vollmar B. [Impact of microcirculatory dysfunction on manifestation of postischemic liver injury]. Chir Gastroenterol. 2002;18(Suppl 1):46-51. German.
27. Vollmar B, Menger MD. Microcirculatory dysfunction in acute pancreatitis. A new concept of pathogenesis involving vasomotion-associated arteriolar constriction and dilation. Pancreatology. 2003;3:181-90.
28. Heideman M, Kaijser B, Gelin LE. Complement activation and hematologic, hemodynamic, and respiratory reactions early after soft-tissue injury. J Trauma. 1978;18:696-700.
29. Blomquist S, Thorne J, Elmer O. Different effects of bleeding and soft-tissue trauma on pulmonary platelet trapping in pigs. J Trauma. 1989;29:866-72.
30. Klinger MH. Platelets and inflammation. Anat Embryol (Berl). 1997;196:1-11.
31. Lu K, Liang CL, Chen HJ, Chen SD, Hsu HC, Chen YC, Hsu FF, Cho CL. Nuclear factor-kappaB-regulated cyclooxygenase-2 expression in surgery-associated paraspinal muscle injury in rats. J Neurosurg Spine. 2003;98:181-7.
32. Katagiri H, Ito Y, Ishii K, Hayashi I, Suematsu M, Yamashina S, Murata T, Narumiya S, Kakita A, Majima M. Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice. Hepatology. 2004;39:139-50.
33. Schwab JM, Beschorner R, Meyermann R, Gozalan F, Schluesener HJ. Persistent accumulation of cyclooxygenase-1-expressing microglial cells and macrophages and transient upregulation by endothelium in human brain injury. J Neurosurg. 2002;96:892-9.
34. Loftin CD, Tiano HF, Langenbach R. Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2. Prostaglandins Other Lipid Mediat. 2002;68-69:177-85.
35. Muscara MN, Vergnolle N, Lovren F, Triggle CR, Elliott SN, Asfaha S, Wallace JL. Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence. Br J Pharmacol. 2000;129:1423-30.
36. Reuter BK, Asfaha S, Buret A, Sharkey KA, Wallace JL. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest. 1996;98:2076-85.
37. Tsukada K, Hasegawa T, Tsutsumi S, Kuwano H. Roles of cyclooxygenase-2 in tissue injury during hemorrhagic shock. Shock. 2000;13:392-6.
38. Nakayama M, Uchimura K, Zhu RL, Nagayama T, Rose ME, Stetler RA, Isakson PC, Chen J, Graham SH. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci USA. 1998;95:10954-9.
39. Cernak I, O'Connor C, Vink R. Inhibition of cyclooxygenase 2 by nimesulide improves cognitive outcome more than motor outcome following diffuse traumatic brain injury in rats. Exp Brain Res. 2002;147:193-9.
40. Sunose Y, Takeyoshi I, Ohwada S, Tsutsumi H, Iwazaki S, Kawata K, Kawashima Y, Tomizawa N, Matsumoto K, Morishita Y. The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model. J Am Coll Surg. 2001;192:54-62.
41. Ito Y, Katagiri H, Ishii K, Kakita A, Hayashi I, Majima M. Effects of selective cyclooxygenase inhibitors on ischemia/reperfusion-induced hepatic microcirculatory dysfunction in mice. Eur Surg Res. 2003;35:408-16.
42. Foitzik T, Hotz HG, Hotz B, Wittig F, Buhr HJ. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis. Hepatogastroenterology. 2003;50:1159-62.
43. Song AM, Bhagat L, Singh VP, Van Acker GG, Steer ML, Saluja AK. Inhibition of cyclooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol. 2002;283:G1166-74.
44. Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen S, Adamis AP. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J. 2002;16:438-40.
45. House SD, Lipowsky HH. Leukocyte-endothelium adhesion: microhemodynamics in mesentery of the cat. Microvasc Res. 1987;34:363-79.
46. Chien S. Role of blood cells in microcirculatory regulation. Microvasc Res. 1985;29:129-51.